𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck. A phase II trial

✍ Scribed by Marco Merlano; Elvio G. Russi; Gianmauro Numico; Ida Colantonio; Ornella Garrone; Antonio Pelissero; Cristina Granetto; Milena Gasco; Gianna Di Costanzo; Abdelhamid Heouaine; Riccardo Vigna Taglianti; Marco Cipolat

Book ID
118496394
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
64 KB
Volume
75
Category
Article
ISSN
0167-8140

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Paclitaxel, cisplatin, and 5-fluorouraci
Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Phase II trial of dose-dense paclitaxel,
Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck
✍ Ricardo Hitt; Antonio Jimeno; Jose MarΓ­a MillΓ‘n; Daniel Castellano; HernΓ‘n CortΓ© πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 4 views

## Abstract ## BACKGROUND The current study evaluated the feasibility and clinical activity of a combination of paclitaxel, cisplatin, 5‐fluorouracil (5‐FU), and leucovorin administered on a biweekly schedule to patients with recurrent or unresectable squamous cell carcinoma of the head and neck (

Cisplatin-5-fluorouracil chemotherapy fo
Cisplatin-5-fluorouracil chemotherapy for advanced inoperable squamous carcinoma of the head and neck
✍ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra πŸ“‚ Article πŸ“… 1987 πŸ› Wiley (John Wiley & Sons) βš– 368 KB πŸ‘ 2 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt